BioAroundWorld Event April 19 & April 20
Host: BioAroundWorld
Co-host :MSQ Ventures
Tuesday, April 19th, 2022
Wednesday, April 20th, 2022
9:00AM-11:00AM ET
Zoom Webinar ID: 828 6082 3915
Agenda
Day 1, April 19th, 2022
9:00AM-9:10AM ET Opening
Vision and Mission of BAW
BAW Founding Members:
Echo Hindle-Yang, Founder & CEO, MSQ Ventures
Joan Shen, Chief Executive Officer and Founder, NeuShen Therapeutics,
Ed Zhang, Co-founder and CEO, Overland Pharmaceutical
Alvin Luk, CEO, Neurophth Therapeutics
Peter Greaney, Head Of Corporate Development, ADC Therapeutics
Ginger Ding, Managing Director, MSQ Ventures
9:10AM-10:40 AM ET Round Table Discussion
Topic 1# Key considerations and strategies accelerating rare disease drug development
Host: Joan Shen, Chief Executive Officer and Founder, NeuShen Therapeutics,
Speakers:
Shawn Xiang, CEO, RareStone Group
Dewan Zeng, Vice President, Head of Search and Evaluation, Business Development, BeiGene
Benjamin Yerxa, CEO, Opus Genetics
Topic 2# Global capital market forecast
Host: Wendy Pan, Partner, Goodwin
Speakers:
Echo Hindle-Yang, Founder & CEO, MSQ Ventures
Shoaib Ghias, Partner, Goodwin
Philipe Gallon, Managing Director, Moelis & Company
Day 2, April 20th, 2022
9:00AM-10:30AM ET Successful Case Study
CASE STUDY #1 Overland & ADCT
Host: Echo Hindle-Yang, Founder & CEO, MSQ Ventures
Speakers:
Ed Zhang, Co-founder and CEO, Overland Pharmaceutical
Peter Greaney, Head Of Corporate Development, ADC Therapeutics
CASE STUDY #2 How to Maximize Your Asset’s Value for Deal Making: A Case Study Presentation by NeoImmuneTech
Speaker: Samuel Zhang, PhD, MBA, Chief Business Officer, NeoImmuneTech, Inc.
CASE STUDY #3 The current landscape and future perspectives of Galectin-3 inhibitors in fibrosis-related diseases and cancer
Speaker: Stephanie Oestreich, Chief Business Officer, Galecto
10:30AM-11:00AM ET Expert Knowledge
Pharmaceutical Patent Listing in China - Impact on Drug Licensing Deals
Bioaroundworld Introduction
Diseases do not recognize borders, and neither should we. Innovative medicines are needed around the world. The constraint of resources, especially among economically marginalized geographies, limits access to new drug treatments.
BioAroundWorld is the first global platform for cross-border knowledge sharing in biopharma sector, bringing together regulatory and industry experts, to promote innovation and accelerate the drug approval across geographies in the most resource-efficient manner.
We hope leaders can find inspiration from our efforts to empower colleagues to collaborate across borders, effectively address the healthcare needs of a diverse global population together, and to build mutual trust and shared understanding.